Prognostic Value of Serum α-HBDH Levels in Patients with Lung Cancer

Overview

Journal World J Surg Oncol

Publisher Biomed Central

Specialties General Surgery
Oncology

Date 2023 Mar 5

PMID 36872314

Authors

Zhi-Min Yuan

Long-Hao Wang

Cheng Chen

Affiliations

Soon will be listed here.

Abstract

Background: The purpose of our study is to investigate the expression level and prognostic value of serum α-hydroxybutyrate dehydrogenase (α-HBDH) in lung cancer (LC) patients.

Method: LC patients treated in the Department of Oncology, Shaanxi Provincial Cancer Hospital from January 2014 to December 2016 were included in this study, all of whom underwent serological detection of α-HBDH prior to admission, and were enrolled in follow-up 5-year survival. Comparing the differences between high group and normal groups based on α-HBDH and LDH expression via clinicopathological parameters and laboratory data. Univariate and multivariate regression and overall survival (OS) were analyzed to explore whether elevated α-HBDH was an independent risk factor for LC, compared to LDH.

Results: Multivariate regression analysis showed that age (P = 0.018), liver metastasis (P = 0.011), α-HBDH (P = 0.015), and neutrophil-to-lymphocyte ratio (NLR) (P = 0.031) were independent prognostic factors affecting OS in LC patients. The overall diagnostic efficacy of α-HBDH (AUC = 0.887) was higher than that of LDH (AUC = 0.709) in the ROC curve. The sensitivity was significantly higher of α-HBDH (sensitivity: 76.06%, specificity: 94.87%) compared with LDH (sensitivity: 49.30%, specificity: 94.87%). The median of OS was more significant in the high-α-HBDH group (6.4 months) than in the normal-α-HBDH group (12.7 months) (P = 0.023). The median of OS was significant in the high-LDH (> 245 U/L) group at 5.8 months and 12.0 months in the normal-LDH (≤ 245 U/L) group (P = 0.068).

Conclusions: Elevated expression of α-HBDH may indicate a poor prognosis of LC patients. It has a higher sensitivity than LDH and can be used as a potential early biomarker and an independent risk factor predicting the prognosis of LC survival.

Citing Articles

Machine Learning-based Prognostic Model for Brain Metastasis Patients: Insights from Blood Test Analysis.

Li R, Liu Z, Wei Z, Huang R, Pei Y, Yang J J Cancer. 2025; 16(2):689-699.

PMID: 39744477 PMC: 11685702. DOI: 10.7150/jca.103847.

Development and validation of an artificial intelligence model for predicting de novo distant bone metastasis in breast cancer: a dual-center study.

Zhang W, Tan Y, Huang Z, Tan Q, Zhang Y, Wei C BMC Womens Health. 2024; 24(1):442.

PMID: 39098907 PMC: 11299401. DOI: 10.1186/s12905-024-03264-z.

Development and validation of AI models using LR and LightGBM for predicting distant metastasis in breast cancer: a dual-center study.

Zhang W, Tan Y, Huang Z, Tan Q, Zhang Y, Chen B Front Oncol. 2024; 14:1409273.

PMID: 38947897 PMC: 11211559. DOI: 10.3389/fonc.2024.1409273.

Association of α-HBDH levels with the severity and recurrence after acute ischemic stroke.

Wang Q, Deng T, Xie Y, Lu H, Zhang T, Gao D Eur J Med Res. 2024; 29(1):347.

PMID: 38926868 PMC: 11201310. DOI: 10.1186/s40001-024-01944-y.

Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy.

Ye J, Zheng L, Chen Z, Wang Q, Liao X, Wang X BMC Urol. 2024; 24(1):62.

PMID: 38509518 PMC: 10953183. DOI: 10.1186/s12894-024-01439-2.

References

Zinellu A, Paliogiannis P, Carru C, Mangoni A . Serum hydroxybutyrate dehydrogenase and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression. Clin Exp Med. 2021; 22(4):499-508. PMC: 8603904. DOI: 10.1007/s10238-021-00777-x. View

Forkasiewicz A, Dorociak M, Stach K, Szelachowski P, Tabola R, Augoff K . The usefulness of lactate dehydrogenase measurements in current oncological practice. Cell Mol Biol Lett. 2020; 25:35. PMC: 7285607. DOI: 10.1186/s11658-020-00228-7. View

Trapani S, Grisolia F, Simonini G, Calabri G, Falcini F . Incidence of occult cancer in children presenting with musculoskeletal symptoms: a 10-year survey in a pediatric rheumatology unit. Semin Arthritis Rheum. 2000; 29(6):348-59. DOI: 10.1053/sarh.2000.5752. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Zukiel R, Nowak S, Jankowski R, Moczko J, Michalak S . [Enzymatic activity in cerebrospinal fluid in the monitoring of the brain lesions following intracranial tumors]. Neurol Neurochir Pol. 1998; 32(2):359-65. View

Fan L, Xu J, Chen X, Tian T, Xie J, Hu J . [Effect of Signal Transduction Pathway Gene Mutations on the One- course Induced Remission Rate and Analysis of Clinical Characteristics in Patients with CBF-AML]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020; 28(3):781-788. DOI: 10.19746/j.cnki.issn.1009-2137.2020.03.011. View

Nasim F, Sabath B, Eapen G . Lung Cancer. Med Clin North Am. 2019; 103(3):463-473. DOI: 10.1016/j.mcna.2018.12.006. View

Xiao W, Liu W, Yin L, Li Y, Lu G, Liu X . Serum hydroxybutyrate dehydrogenase as an early predictive marker of the severity of acute pancreatitis: a retrospective study. BMC Gastroenterol. 2020; 20(1):393. PMC: 7678267. DOI: 10.1186/s12876-020-01521-7. View

Augoff K, Hryniewicz-Jankowska A, Tabola R . Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. Cancer Lett. 2014; 358(1):1-7. DOI: 10.1016/j.canlet.2014.12.035. View

10.

Ding J, Karp J, Emadi A . Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments. Cancer Biomark. 2017; 19(4):353-363. DOI: 10.3233/CBM-160336. View

11.

Serpa M, Franco S, Repolho D, Branco F, Gramaca J, Junior J . An Unusual Case of Primary Retroperitoneal Germ Cell Tumour in a Young Man. Eur J Case Rep Intern Med. 2019; 5(7):000900. PMC: 6346782. DOI: 10.12890/2018_000900. View

12.

Gamucci T, Zampa G . Cardiotoxicity of 5-fluorouracil. Tumori. 1980; 66(5):635-6. DOI: 10.1177/030089168006600511. View

13.

Gonzalez Buitrago J, Pastor I, Corrales J . Cytoplasmic enzyme activities in human hypernephroma compared with normal renal cortical tissue. Urol Int. 1988; 43(1):32-4. DOI: 10.1159/000281299. View

14.

Wu Y, Lu C, Pan N, Zhang M, An Y, Xu M . Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases. Sci Rep. 2021; 11(1):12997. PMC: 8217520. DOI: 10.1038/s41598-021-92430-6. View

15.

Mouchli M, Reddy S, Gerrard M, Boardman L, Rubio M . Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article. Ann Hepatol. 2020; 22:100249. DOI: 10.1016/j.aohep.2020.08.067. View

16.

Khanolkar M, Sirsat A, Deshmane V, Kamat M . Serum lactate dehydrogenase, alpha-hydroxybutyrate dehydrogenase and ratio of alpha-hydroxybutyrate dehydrogenase to lactate dehydrogenase in testicular tumours. Indian J Cancer. 1990; 27(4):243-9. View

17.

Fast J, Kubat K, van Haelst U, SCHUURMANS STEKHOVEN J . The usefulness of an endomyocardial biopsy in heart disease of unknown etiology. Int J Cardiol. 1986; 11(3):317-28. DOI: 10.1016/0167-5273(86)90036-7. View

18.

Pencina M, DAgostino R, Pencina K, Janssens A, Greenland P . Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol. 2012; 176(6):473-81. PMC: 3530349. DOI: 10.1093/aje/kws207. View

19.

Franken N, Strootman E, Hollaar L, van der Laarse A, Wondergem J . Myocardial enzyme activities in plasma after whole-heart irradiation in rats. J Cancer Res Clin Oncol. 2000; 126(1):27-32. DOI: 10.1007/pl00008461. View

20.

Zhang X, Guo M, Fan J, Lv Z, Huang Q, Han J . Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis. Cancer Biomark. 2016; 16(3):415-23. DOI: 10.3233/CBM-160580. View